Driving and Dementia: This study aims to investigate the positives and negatives associated with people with dementia continuing to drive and to identify the factors associated with the decision of people with dementia to stop driving.

Not Applicable

• Conditions: Dementia; Alzheimer's Disease; Neurological - Dementias; Neurological - Alzheimer's disease

• Registration Number: ACTRN12615001374550
• Lead Sponsor: John Walsh Centre for Rehabilitation Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-12-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

People aged 65 and older
People who have had a diagnosis of Dementia or Alzheimer’s disease from the
Hornsby Ku-ring-gai memory clinic in the previous six months
Be driving at the time of recruitment
Participant does not need to have a carer/NOK to be part of the trial but if they do nominate a carer/NOK they will be asked to complete an interview as well.

Exclusion Criteria

Non English speaking persons
People with Parkinson’s disease or other degenerative illnesses that may inhibit
their ability to drive over time (e.g. poor vision, epilepsy)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of this study is to identify the factors associated with the decision of people recently diagnosed with dementia to stop driving. This will be assessed over two years using 5 interviews designed especially for this study ), over a period of 2 years. Carers or Next of Kin of participants will also be interviewed a total of 5 times.[Questionnaires will be completed with participants and carers at baseline, at six months, at 12 months, at 18 months and at 24 months. Three interviews (baseline, 12 month interview and 24 month interview) will be done face to face at the participants home and two (6 and 18 months) will be done over the telephone.]

Secondary Outcome Measures

Name	Time	Method
Quality of life of participant[EQ5D-L and Visual Analogue Scale will be used at baseline, at six months, at 18 months and at 12 months.];Health state of Carer. Carers will simply be asked whether they consider their health to be Excellent, very good, good, fair or poor, at all 5 interviews. [The health state of carer question will be asked at baseline, 6 months, 12 months, 18 months and 24 months.];Cognitive Decline of Participants will be measured by using the Mini Mental Examination (MMSE) and the Montreal Cognitive Assessment (MOCA)[Cognition will be measured at Baseline, 12 months and at 24 months at the face to face interviews conducted in participants homes.]